Back to Index

AGIIL Daily Market Report

Date Range: 2024-07-15 to 2026-10-26 | Evidence Type: Daily-only

DAILY-ONLY FALLBACK: This security has current daily OHLCV history but lacks the intraday files required by the legacy execution simulator. The page therefore reports observable daily-market evidence and current research candidates only. It does not claim intraday backtest performance or a trading recommendation.

Current Snapshot

Current Snapshot — AGIIL Report
Metric Value
Latest closed session 2026-10-26
Latest close 200.5500
20-session average turnover 158606686.30
Distance from 252-session high -52.12%

Trailing Price Returns

Trailing Price Returns — AGIIL Report
Sessions Return
1 -6.55%
5 -19.83%
20 -26.12%
60 -34.27%
120 -50.72%
250 -25.53%

These are trailing observations ending on the latest closed session, not forward returns from a setup.

Current Market Intelligence Candidates

Current Market Intelligence Candidates — AGIIL Report
Archetype Regime Primary horizon Strength First rejection risk
MEAN_REVERSION_CAPITULATION BEAR_PERSISTENT 20 1.72 Continued trend momentum breakdown
PRICE_DISLOCATION BEAR_PERSISTENT 120 0.34 Continued price deterioration or adverse fundamental evidence

Evidence Limits

Fundamental Research

Fundamental Research — AGIIL Report
Field Value
Statement scope FULL_STATEMENTS
Latest annual period 2026-03-31
Statement completeness 100%
Revenue growth 8.52%
Net margin 26.91%
Return on equity 20.41%
Debt/equity 0.40
Operating cash flow/net income -0.48
Free-cash-flow margin -18.55%
Trailing P/E 39.08
Price/book 8.15

Source: EODHD retrieved 2026-10-09T23:40:12.610097+00:00.

QA flags: balance_sheet_equation: difference=199713000.00; weak_cash_conversion: operating cash flow/net income below 0.5

Missing statements mean data is unavailable. Balance-sheet equation flags require checking accounting definitions and units. Weak cash conversion and high leverage are financial risk observations, not necessarily data errors. A summary-only record cannot establish financial quality.

Provider-standardized figures are a research aid. Review consolidated filings, units, restatements, accounting policies, and QA flags before investment use.